Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2606)
All Articles published online
|
Publishing Process of This Article
|
Sep 15, 2022 (publication date) through Apr 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liu QH, Zhang JW, Xia L, Wise SG, Hambly BD, Tao K, Bao SS. Clinical implications of interleukins-31, 32, and 33 in gastric cancer. World J Gastrointest Oncol 2022; 14(9): 1808-1822 [PMID: 36187404 DOI: 10.4251/wjgo.v14.i9.1808] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v14/i9/1808.htm |
| Number | Citing Articles |
| 1 |
Qiang Wang, Linna Ma, Caiping An, Steven G. Wise, Shisan Bao. The role of IL-38 in intestinal diseases - its potential as a therapeutic target. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1051787
|
| 2 |
Laura Francesca Pisani, Isabella Teani, Maurizio Vecchi, Luca Pastorelli. Interleukin-33: Friend or Foe in Gastrointestinal Tract Cancers?. Cells 2023; 12(11): 1481 doi: 10.3390/cells12111481
|
| 3 |
Yang Si, Jiwei Zhang, Shisan Bao, Steven G. Wise, Yuli Wang, Yanfang Zhang, Yuhong Tang. IL-32 and IL-34 in hepatocellular carcinoma. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.1051113
|
| 4 |
Annesha Chatterjee, Jordana Maria Azevedo-Martins, Matthew D Stachler. Interleukin-33 as a Potential Therapeutic Target in Gastric Cancer Patients: Current Insights. OncoTargets and Therapy 2023; : 675 doi: 10.2147/OTT.S389120
|